David Abernethy

1.6k total citations
35 papers, 992 citations indexed

About

David Abernethy is a scholar working on Neurology, Pathology and Forensic Medicine and Cognitive Neuroscience. According to data from OpenAlex, David Abernethy has authored 35 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 9 papers in Pathology and Forensic Medicine and 7 papers in Cognitive Neuroscience. Recurrent topics in David Abernethy's work include Multiple Sclerosis Research Studies (9 papers), Motor Control and Adaptation (5 papers) and Autoimmune Neurological Disorders and Treatments (4 papers). David Abernethy is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Motor Control and Adaptation (5 papers) and Autoimmune Neurological Disorders and Treatments (4 papers). David Abernethy collaborates with scholars based in New Zealand, Australia and United Kingdom. David Abernethy's co-authors include Richard J. Siegert, Mark Weatherall, Jared G. Smith, John McDowall, David N. Harper, S. Harding, Anne Camille La Flamme, Clive E. Sabel, Bruce Taylor and John F. Pearson and has published in prestigious journals such as PLoS ONE, Brain and The Journal of Urology.

In The Last Decade

David Abernethy

32 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Abernethy New Zealand 16 384 244 217 97 91 35 992
Mikołaj A. Pawlak Poland 19 418 1.1× 207 0.8× 183 0.8× 89 0.9× 35 0.4× 48 1.1k
M. Haupts Germany 18 423 1.1× 330 1.4× 145 0.7× 222 2.3× 151 1.7× 44 1.2k
Annette Baumgärtner Germany 17 217 0.6× 133 0.5× 381 1.8× 84 0.9× 40 0.4× 33 880
Sabrina Realmuto Italy 18 198 0.5× 237 1.0× 209 1.0× 206 2.1× 49 0.5× 30 861
Omar Ghaffar Canada 24 422 1.1× 321 1.3× 147 0.7× 175 1.8× 617 6.8× 35 2.4k
G Aimard France 17 362 0.9× 603 2.5× 475 2.2× 250 2.6× 106 1.2× 85 1.5k
Serena D’Agostini Italy 15 388 1.0× 67 0.3× 292 1.3× 39 0.4× 44 0.5× 46 962
Matti Iivanainen Finland 21 179 0.5× 321 1.3× 276 1.3× 184 1.9× 224 2.5× 50 1.4k
Nancy Madigan United States 13 172 0.4× 273 1.1× 151 0.7× 41 0.4× 19 0.2× 16 817
Alessandro Castriota-Scanderbeg Italy 19 372 1.0× 115 0.5× 169 0.8× 49 0.5× 16 0.2× 35 1.1k

Countries citing papers authored by David Abernethy

Since Specialization
Citations

This map shows the geographic impact of David Abernethy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Abernethy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Abernethy more than expected).

Fields of papers citing papers by David Abernethy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Abernethy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Abernethy. The network helps show where David Abernethy may publish in the future.

Co-authorship network of co-authors of David Abernethy

This figure shows the co-authorship network connecting the top 25 collaborators of David Abernethy. A scholar is included among the top collaborators of David Abernethy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Abernethy. David Abernethy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abernethy, David, Jason A. Bennie, & Toby Pavey. (2025). Joint Effects of Physical Activity and Body Mass Index on Prevalent Diabetes in a Nationally Representative Sample of 1.9 Million US Adults. Journal of Diabetes Research. 2025(1). 7466757–7466757. 1 indexed citations
3.
Flamme, Anne Camille La, David Abernethy, Dalice Sim, et al.. (2020). Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial. BMJ Neurology Open. 2(1). e000060–e000060. 9 indexed citations
4.
Horsham, Caitlin, et al.. (2020). Testing Wearable UV Sensors to Improve Sun Protection in Young Adults at an Outdoor Festival: Field Study. JMIR mhealth and uhealth. 8(9). e21243–e21243. 12 indexed citations
5.
Pearson, John F., Glynnis Clarke, Deborah Mason, et al.. (2016). Multiple Sclerosis impact on employment and income in New Zealand. Acta Neurologica Scandinavica. 136(3). 223–232. 26 indexed citations
6.
Pearson, John F., Bruce Taylor, David H. Miller, et al.. (2016). Disability profile of multiple sclerosis in New Zealand. Journal of Clinical Neuroscience. 28. 97–101. 4 indexed citations
7.
Harding, S., et al.. (2014). Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis. Immunology and Cell Biology. 92(6). 509–517. 87 indexed citations
8.
Bourke, David, Richard Roxburgh, Angela Vincent, et al.. (2013). Hypoventilation in glycine-receptor antibody related progressive encephalomyelitis, rigidity and myoclonus. Journal of Clinical Neuroscience. 21(5). 876–878. 12 indexed citations
9.
Taylor, Bruce, John F. Pearson, Glynnis Clarke, et al.. (2010). MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Multiple Sclerosis Journal. 16(12). 1422–1431. 75 indexed citations
10.
Taylor, Bruce, Ann Richardson, John F. Pearson, et al.. (2009). 16. Prevalence of multiple sclerosis in New Zealand. Journal of Clinical Neuroscience. 16(11). 1529–1529. 8 indexed citations
11.
Siegert, Richard J., et al.. (2008). A meta-analysis of performance on simple span and more complex working memory tasks in Parkinson's disease.. Neuropsychology. 22(4). 450–461. 47 indexed citations
12.
Hay‐Smith, Jean, Richard J. Siegert, Mark Weatherall, & David Abernethy. (2007). Bladder and bowel dysfunction in multiple sclerosis: A review of treatment effectiveness. 13(3). 81–89. 6 indexed citations
13.
Smith, Jared G., David N. Harper, David Gittings, & David Abernethy. (2007). The effect of Parkinson’s disease on time estimation as a function of stimulus duration range and modality. Brain and Cognition. 64(2). 130–143. 81 indexed citations
14.
Siegert, Richard J., et al.. (2006). Is implicit sequence learning impaired in Parkinson's disease? A meta-analysis.. Neuropsychology. 20(4). 490–495. 146 indexed citations
15.
Delahunt, Brett, David Abernethy, Carol Johnson, & John N. Nacey. (2003). Prostate Carcinoma And The Lambert-Eaton Myasthenic Syndrome. The Journal of Urology. 169(1). 278–279. 12 indexed citations
16.
Siegert, Richard J., et al.. (2002). Self-Initiated Versus Externally Cued Reaction Times in Parkinson's Disease. Journal of Clinical and Experimental Neuropsychology. 24(2). 146–153. 51 indexed citations
17.
Smith, Jared G., Richard J. Siegert, John McDowall, & David Abernethy. (2001). Preserved Implicit Learning on Both the Serial Reaction Time Task and Artificial Grammar in Patients with Parkinson's Disease. Brain and Cognition. 45(3). 378–391. 83 indexed citations
18.
Siegert, Richard J., et al.. (1999). Clustering and Switching in Verbal Fluency in Parkinson's Disease. New Zealand journal of psychology. 28(1). 61–7. 23 indexed citations
19.
McDowall, John, et al.. (1998). Implicit Learning in Parkinson's Disease: Evidence from a Verbal Version of the Serial Reaction Time Task. Journal of Clinical and Experimental Neuropsychology. 20(3). 413–418. 62 indexed citations
20.
Bradley, J. L., David Abernethy, R. H. M. King, J. R. Muddle, & P. K. Thomas. (1998). Neural architecture in transected rabbit sciatic nerve after prolonged nonreinnervation. Journal of Anatomy. 192(4). 529–538. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikołaj A. Pawlak Breakdown of academic impact, for papers by M. Haupts Breakdown of academic impact, for papers by Annette Baumgärtner Breakdown of academic impact, for papers by Sabrina Realmuto Breakdown of academic impact, for papers by Omar Ghaffar Breakdown of academic impact, for papers by G Aimard Breakdown of academic impact, for papers by Serena D’Agostini Breakdown of academic impact, for papers by Matti Iivanainen Breakdown of academic impact, for papers by Nancy Madigan Breakdown of academic impact, for papers by Alessandro Castriota-Scanderbeg
Rankless by CCL
2026